Seronegative patients vaccinated with cytomegalovirus gB-MF59 vaccine have evidence of neutralising antibody responses against gB early post-transplantation. [electronic resource]
Producer: 20200430Description: 45-54 p. digitalISSN:- 2352-3964
- Adjuvants, Immunologic
- Antibodies, Neutralizing -- blood
- Antibodies, Viral -- blood
- Clinical Trials, Phase II as Topic
- Cytomegalovirus -- immunology
- Cytomegalovirus Infections -- blood
- Enzyme-Linked Immunosorbent Assay
- Humans
- Immunization, Secondary
- Immunocompromised Host
- Neutralization Tests
- Organ Transplantation -- adverse effects
- Polysorbates
- Randomized Controlled Trials as Topic
- Squalene
- Time Factors
- Vaccination
- Viral Envelope Proteins -- immunology
- Viral Vaccines -- administration & dosage
- Viremia -- prevention & control
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.